Can a headset tune out caregiver stress? new trial aims to find out

NCT ID NCT05209438

First seen Jun 02, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This pilot study tests whether a device called Cereset Research can help caregivers of people with dementia who feel stressed, anxious, or have trouble sleeping. The device plays tones that echo the brain's own rhythms, aiming to improve heart rate variability and reduce stress. Twenty caregivers will use the device over four weeks, and researchers will measure changes in blood pressure, heart rate, and self-reported stress and sleep quality.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAREGIVERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wake Forest University Health Sciences

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cereset Research device (brainwave echo via audible tones)

What this could lead to

If it works, this could offer a drug-free way to help caregivers manage stress and improve heart health.

What could go wrong

This is a very small pilot study with only 20 participants, so results may not apply widely. The device is experimental and not yet proven effective.

Conditions

The condition(s) this trial relates to.

anxiety disorder dementia insomnia primary dysautonomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.